| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $443.4M | +17.9% |
| R&D Expense | $67.5M | +13.3% |
| SG&A Expense | $119.5M | +15.6% |
| Operating Income | $175.0M | +36.1% |
| Interest Expense | $40.4M | -23.2% |
| Pre-tax Income | $140.9M | +73.6% |
| Income Tax | $29.8M | +80.2% |
| Net Income | $111.1M | +71.9% |
| EPS (Basic) | $1.02 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $73.1M | -7.2% |
| Short-term Investments | $63.6M | +101.5% |
| Accounts Receivable | $28.6M | -16.1% |
| Current Assets | $304.0M | +17.6% |
| Total Assets | $1.04B | -5.3% |
| Current Liabilities | $79.8M | +9.1% |
| Long-term Debt | $418.5M | -12.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $158.1M | -25.6% |
| Capital Expenditures | $1.8M | -0.8% |
| Investing Cash Flow | -$40.3M | -67.6% |
| Financing Cash Flow | -$123.5M | +24.8% |
| Free Cash Flow | $156.3M | -25.8% |
| +72.9% |
| EPS (Diluted) | $0.99 | +73.7% |
| Total Liabilities |
| $558.8M |
| -20.3% |
| Stockholders' Equity | $480.5M | +21.2% |